📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pre-clinical development of AP4B1 gene replacement therapy for hereditary spastic paraplegia type 47. (2024)

First Author: Wiseman JP

Attributed to: JPND - Multicellular organoids: modeling, mechanisms and therapy development for C9ORF72-associated neurodegeneration. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44321-024-00148-5

PubMed Identifier: 39358605

Publication URI: http://europepmc.org/abstract/MED/39358605

Type: Journal Article/Review

Volume: 16

Parent Publication: EMBO molecular medicine

Issue: 11

ISSN: 1757-4676